Efficacy and Safety of Cilostazol Therapy in Ischemic Stroke: A Meta-analysis
- 1 May 2015
- journal article
- research article
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 24 (5) , 930-938
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Cilostazol Inhibits Accumulation of Triglyceride in Aorta and Platelet Aggregation in Cholesterol-Fed RabbitsPLOS ONE, 2012
- Antithrombotic and Thrombolytic Therapy for Ischemic StrokeChest, 2012
- Efficacy and Safety of Combination Antiplatelet Therapies in Patients With Symptomatic Intracranial Atherosclerotic StenosisStroke, 2011
- Guidelines for the Primary Prevention of StrokeStroke, 2011
- Cilostazol protects against hemorrhagic transformation in mice transient focal cerebral ischemia-induced brain damageNeuroscience Letters, 2009
- Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic StrokeStroke, 2008
- The Headache-Inducing Effect of Cilostazol in Human VolunteersCephalalgia, 2006
- Risk of Hemorrhagic Stroke With Aspirin UseStroke, 2005
- Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial StenosisStroke, 2005
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996